Midday announcement: GLORIA PHARMA plans to sign an agreement to resolve the debt dispute related to the equity transfer of GLORIA BIOZhitong·Nov 3, 2025 at 10:06 PM002437+0.35%
GLORIA PHARMA: Puxing Puli plans to transfer 20.64% equity of GLORIA PHARMA to repay the debts owed by Puxing Puli to the companyZhitong·Nov 3, 2025 at 10:01 PM002437+0.35%
GLORIA PHARMA: Provides guarantees for 40 million bank credit for two wholly-owned subsidiariesZhitong·Oct 13, 2025 at 03:41 AM002437+0.35%
GLORIA PHARMA: Net profit in the first half of 2025 increased by 7.56% year-on-yearZhitong·Aug 26, 2025 at 05:40 AM002437+0.35%
GLORIA PHARMA: Injectable multiple vitamins pass consistency evaluationZhitong·Jun 24, 2025 at 04:34 AM002437+0.35%
GLORIA PHARMA's subsidiary signed a marketing service agreement with Eisai China Pharmaceutical for Mecobalamin InjectionZhitong·Jun 3, 2025 at 03:39 AM002437+0.35%
Some directors and executives of GLORIA PHARMA plan to reduce their holdings by a total of no more than 1.4346 million sharesZhitong·May 29, 2025 at 07:31 AM002437+0.35%
GLORIA PHARMA: Three senior executives plan to collectively reduce their holdings by 0.0639% of the company's sharesZhitong·May 29, 2025 at 06:41 AM002437+0.35%
Pharmaceutical stocks surge, Pharscin Pharma and GLORIA PHARMA hit the limit upZhitong·May 26, 2025 at 08:51 PM002907+2.41%002437+0.35%
GLORIA PHARMA. and Xinghe Pharmaceutical signed a joint promotion agreement for Pemabertinib tabletsZhitong·May 26, 2025 at 04:29 AM002437+0.35%
The chemical pharmaceutical sector has seen a short-term surge, with ApicHope rising over 10%Zhitong·May 19, 2025 at 08:32 PM300254+3.85%300723+4.13%
GLORIA PHARMA: The company currently does not have any pediatric medications among its sold pharmaceuticalsZhitong·Apr 28, 2025 at 08:20 PM002437+0.35%
GLORIA PHARMA released its first-quarter performance, with a net profit attributable to the parent company of 60.2523 million yuan, a year-on-year increase of 15.24%Zhitong·Apr 25, 2025 at 06:23 AM002437+0.35%
GLORIA PHARMA. repurchased shares for the first time, buying back 23.3037 million shares at a cost of approximately 57.65 million yuanZhitong·Mar 10, 2025 at 04:58 AM002437+0.35%
